Institutional Ownership
An2 Therapeutics Inc
CUSIP 037326105COMANTXQ1 2026
13D / 13G Filings
41
Schedule 13D/13G on record
Beneficial Filers
19
Distinct reporting persons
Largest Stake
19.6%
Max % of class reported
Institutional Holders
49
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
41 filings · latest Mar 13, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 13, 2026 | Vivo Opportunity Fund Holdings, L.P. | 13G | 8.0% | 2.86M | SEC |
| 2 | Mar 13, 2026 | Integrated Core Strategies (Us) LLC | 13G | 6.3% | 2.24M | SEC |
| 3 | Feb 17, 2026 | Almitas Capital LLC | 13G | 5.4% | 2.98M | SEC |
| 4 | Feb 13, 2026 | Eric Easom | 13G/A | 7.9% | 2.23M | SEC |
| 5 | Nov 14, 2025 | Almitas Capital LLC | 13G | 11.0% | 1.43M | SEC |
| 6 | Jun 18, 2025 | Bml Investment Partners, L.P. | 13D/A | 1.4% | — | SEC |
| 7 | Jun 4, 2025 | Coastlands Capital LP | 13G | 9.3% | — | SEC |
| 8 | May 30, 2025 | Bml Investment Partners, L.P. | 13D/A | 10.7% | — | SEC |
| 9 | May 7, 2025 | Bml Investment Partners, L.P. | 13D | 19.1% | — | SEC |
| 10 | Feb 28, 2025 | Adjuvant Global Health Technology Fund, L.P. | 13G/A | 7.9% | 2.37M | SEC |
31 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for An2 Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Vivo Capital, LLC | 3.15M | $10.79M |
| 2 | Commodore Capital LP | 2.33M | $7.98M |
| 3 | Millennium Management LLC | 2.22M | $7.60M |
| 4 | Spruce Street Capital LP | 1.66M | $5.58M |
| 5 | Almitas Capital LLC | 1.48M | $5.06M |
| 6 | Adage Capital Partners Gp, L.L.C. | 1.00M | $3.42M |
| 7 | Woodline Partners LP | 993.7K | $3.40M |
| 8 | Boxer Capital Management, LLC | 749.0K | $2.56M |
| 9 | Stonepine Capital Management, LLC | 713.8K | $2.44M |
| 10 | Ameriprise Financial Inc | 696.2K | $2.38M |